These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Acute ischemic coronary artery disease and ischemic stroke: similarities and differences. Fisher M; Folland E Am J Ther; 2008; 15(2):137-49. PubMed ID: 18356634 [TBL] [Abstract][Full Text] [Related]
4. Drug therapy of neurovascular disease. Weinberger J; Terashita D Heart Dis; 1999; 1(3):163-78. PubMed ID: 11720620 [TBL] [Abstract][Full Text] [Related]
5. The utility of cardiovascular drugs in the treatment of cerebrovascular disease. Bösel J; Amiri H Curr Opin Investig Drugs; 2010 Sep; 11(9):1015-24. PubMed ID: 20730696 [TBL] [Abstract][Full Text] [Related]
6. Drug therapy of neurovascular disease. Weinberger J; Frishman WH; Terashita D Cardiol Rev; 2003; 11(3):122-46. PubMed ID: 12705843 [TBL] [Abstract][Full Text] [Related]
7. Integrated brain restoration after ischemic stroke--medical management, risk factors, nutrients, and other interventions for managing inflammation and enhancing brain plasticity. Kidd PM Altern Med Rev; 2009 Mar; 14(1):14-35. PubMed ID: 19364191 [TBL] [Abstract][Full Text] [Related]
9. Are anticoagulants better than antiplatelet agents for treatment of acute ischemic stroke? Griffin G Am Fam Physician; 2003 Oct; 68(7):1307-8. PubMed ID: 14567484 [No Abstract] [Full Text] [Related]
10. Recurrent stroke: where do we stand with the secondary prevention of noncardioembolic ischaemic strokes? Talelli P; Greenwood RJ Ther Adv Cardiovasc Dis; 2008 Oct; 2(5):387-405. PubMed ID: 19124436 [TBL] [Abstract][Full Text] [Related]
12. Treating acute ischemic stroke. Fisher M; Bastan B Curr Opin Drug Discov Devel; 2008 Sep; 11(5):626-32. PubMed ID: 18729014 [TBL] [Abstract][Full Text] [Related]
13. Antiplatelets, ACE inhibitors, and statins combination reduces stroke severity and tissue at risk. Kumar S; Savitz S; Schlaug G; Caplan L; Selim M Neurology; 2006 Apr; 66(8):1153-8; discussion 1135. PubMed ID: 16636230 [TBL] [Abstract][Full Text] [Related]
14. Current practice of antithrombotic treatment in ischemic stroke: a survey among Hungarian neurologists. Sztriha LK; Vécsei L Ideggyogy Sz; 2008 May; 61(5-6):148-54. PubMed ID: 18567389 [TBL] [Abstract][Full Text] [Related]
15. Is prestroke use of angiotensin-converting enzyme inhibitors associated with better outcome? Chitravas N; Dewey HM; Nicol MB; Harding DL; Pearce DC; Thrift AG Neurology; 2007 May; 68(20):1687-93. PubMed ID: 17502550 [TBL] [Abstract][Full Text] [Related]
16. Pre-stroke use of antihypertensives, antiplatelets, or statins and early ischemic stroke outcomes. Yu AY; Keezer MR; Zhu B; Wolfson C; Côté R Cerebrovasc Dis; 2009; 27(4):398-402. PubMed ID: 19276623 [TBL] [Abstract][Full Text] [Related]
17. SPASE-I: a multicenter observational study on pharmacological treatment of acute stroke in the elderly. The Italian Study of Pharmacological Treatment of Acute Stroke in the Elderly Group. Altieri M Neurol Sci; 2002 Apr; 23(1):23-8. PubMed ID: 12111617 [TBL] [Abstract][Full Text] [Related]
18. Lipid-lowering drugs in ischemic stroke prevention and their influence on acute stroke outcome. Fuentes B; Martínez-Sánchez P; Díez-Tejedor E Cerebrovasc Dis; 2009; 27 Suppl 1():126-33. PubMed ID: 19342842 [TBL] [Abstract][Full Text] [Related]
20. Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat. Zhang L; Zhang ZG; Ding GL; Jiang Q; Liu X; Meng H; Hozeska A; Zhang C; Li L; Morris D; Zhang RL; Lu M; Chopp M Circulation; 2005 Nov; 112(22):3486-94. PubMed ID: 16316970 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]